C-peptide and diabetic kidney disease (Q34540591)

2 August 2017

1 reference

title

C-peptide and diabetic kidney disease (English)

1 reference

2 August 2017

N J Brunskill

1 reference

2 August 2017

language of work or name

English

0 references

publication date

19 September 2016

1 reference

Journal of Internal Medicine

2 August 2017

published in

1 reference

2 August 2017

volume

281

1 reference

2 August 2017

1 reference

2 August 2017

page(s)

41-51

1 reference

Changing trends in end-stage renal disease due to diabetes in the United kingdom

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

Temporal Trends in the Prevalence of Diabetic Kidney Disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

How to Protect the Kidney in Diabetic Patients: With Special Reference to IDDM

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

Glomerular structure in IDDM women with low glomerular filtration rate and normal urinary albumin excretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

Albuminuria and renal insufficiency prevalence guides population screening: results from the NHANES III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

Sulodexide fails to demonstrate renoprotection in overt type 2 diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

New susceptibility loci associated with kidney disease in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

Genetics of Kidneys in Diabetes (GoKinD) study: a genetics collection available for identifying genetic susceptibility factors for diabetic nephropathy in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

Genomewide linkage scan for diabetic renal failure and albuminuria: the FIND study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

Influence of insertion/deletion polymorphism in the ACE-I gene on the progression of diabetic glomerulopathy in type 1 diabetic patients with microalbuminuria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

Activation of the renal renin-angiotensin system in diabetes--new concepts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

Role of endothelial nitric oxide synthase in diabetic nephropathy: lessons from diabetic eNOS knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

High glucose-induced transforming growth factor beta1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

Biochemistry and molecular cell biology of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

The pathobiology of diabetic complications: a unifying mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

Molecular understanding of hyperglycemia's adverse effects for diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

Role of advanced glycation end products in diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

Inflammation and the pathogenesis of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

Molecular mechanisms of diabetic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

Cellular and physiological effects of C-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

The clinical potential of C-peptide replacement in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

Specific binding of the C-peptide of proinsulin to cultured B-cells from a transplantable rat islet cell tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

Specific binding of proinsulin C-peptide to human cell membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

Evidence for an interaction between proinsulin C-peptide and GPR146

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

C-peptide, Na+,K(+)-ATPase, and diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

Reduction of erythrocyte (Na+-K+)ATPase activity in type 1 (insulin-dependent) diabetic subjects and its activation by homologous plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

Erythrocyte Na/K ATPase activity and diabetes: relationship with C-peptide level

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

Effects of proinsulin C-peptide on nitric oxide, microvascular blood flow and erythrocyte Na+,K+-ATPase activity in diabetes mellitus type I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

C-peptide stimulates Na+,K+-ATPase activity via PKC alpha in rat medullary thick ascending limb

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

C-peptide increases Na,K-ATPase expression via PKC- and MAP kinase-dependent activation of transcription factor ZEB in human renal tubular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

Mammalian MAP kinase signalling cascades

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

Map kinase signaling pathways and hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

Proinsulin C-peptide activates cAMP response element-binding proteins through the p38 mitogen-activated protein kinase pathway in mouse lung capillary endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

Potent activation of multiple signalling pathways by C-peptide in opossum kidney proximal tubular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

C-peptide stimulates ERK1/2 and JNK MAP kinases via activation of protein kinase C in human renal tubular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

Stimulation of endothelial nitric oxide synthase by proinsulin C-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

Prevention of VEGF-mediated microvascular permeability by C-peptide in diabetic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

C-peptide prevents hyperglycemia-induced endothelial apoptosis through inhibition of reactive oxygen species-mediated transglutaminase 2 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

C-peptide activates AMPKα and prevents ROS-mediated mitochondrial fission and endothelial apoptosis in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

C-peptide reduces high-glucose-induced apoptosis of endothelial cells and decreases NAD(P)H-oxidase reactive oxygen species generation in human aortic endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

Chronic diabetic nephropathy: role of inducible nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

Dynamic localization and functional implications of C-peptide might for suppression of iNOS in high glucose-stimulated rat mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

Ligand-independent activation of peroxisome proliferator-activated receptor-gamma by insulin and C-peptide in kidney proximal tubular cells: dependent on phosphatidylinositol 3-kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

C-peptide signals via Galpha i to protect against TNF-alpha-mediated apoptosis of opossum kidney proximal tubular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

Peroxisome proliferator-activated receptor gamma and metabolic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

Urinary and renal interstitial concentrations of TNF-alpha increase prior to the rise in albuminuria in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

The role of TNF-alpha in diabetic nephropathy: pathogenic and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

Production of tumor necrosis factor by rat mesangial cells in response to bacterial lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

Tumor necrosis factor signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

C-peptide reverses TGF-beta1-induced changes in renal proximal tubular cells: implications for treatment of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

Proinsulin C-peptide antagonizes the profibrotic effects of TGF-beta1 via up-regulation of retinoic acid and HGF-related signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

Human C-peptide acutely lowers glomerular hyperfiltration and proteinuria in diabetic rats: a dose-response study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

Effects of C-peptide on glomerular and renal size and renal function in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

C-peptide prevents glomerular hypertrophy and mesangial matrix expansion in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

C-peptide replacement improves weight gain and renal function in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

Influence of C-peptide on early glomerular changes in diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

Renoprotective effects of C-peptide in the Dahl salt-sensitive rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

Proinsulin c-peptide exerts beneficial effects in endotoxic shock in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

C-Peptide Ameliorates Kidney Injury Following Hemorrhagic Shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

The influence of human C-peptide on renal function and glucose utilization in type 1 (insulin-dependent) diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with Type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

Islet transplantation is associated with improvement of renal function among uremic patients with type I diabetes mellitus and kidney transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

Islet transplants and impact on secondary diabetic complications: does C-Peptide protect the kidney?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

C-peptide as a Therapy for Kidney Disease: A Systematic Review and Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12548

21 January 2018

Identifiers

DOI

10.1111/JOIM.12548

1 reference

2 August 2017

1 reference